Rebif New Formulation (RNF) Quality of Life (QOL) Study

Clinical trial NCT00472797 · COMPLETED

Trial details

NCT number: NCT00472797
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2007-04-01
Primary completion: 2009-02-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.